HDT bio's Rapid-Response Roadmap for RNA vaccines (R4) project granted a five-year subaward for $2M per year SEATTLE, Sept. 17, 2024 /PRNewswire/ -- HDT Bio Corp., a clinical-stage ...

Two key players looking to help Kiwi farmers reduce their emissions have given a new company some additional funding to craft a methane vaccine ... to Lucidome Bio to fund their research.

Last year was the first year that the US had vaccines available to protect against all three major respiratory viruses — Covid-19, flu and RSV — but vaccine uptake was low for the season.

MinervaX, a privately-held Danish biotechnology company developing a vaccine against Group B Streptococcus (GBS), and Wacker Biotech, a CDMO, agreed to collaborate on the manufacture of MinervaX ...

JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web ...

JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web ...

At a press briefing, Health Secretary Ted Herbosa said President Ferdinand “Bongbong” Marcos Jr. fully supports the NIP with an increased budget of P2.3 billion to fund the vaccine acquisition and ...

The potential of mRNA vaccines was established during the COVID-19 pandemic. Now, a new wave of candidates could soon hit the market for cancer, influenza and more. The arrival of the COVID-19 ...

While one political analyst believes Opposition Leader Kamla Persad-Bissessar’s criticisms of the COVID-19 vaccine are irrelevant, another analyst says her comments may have been based on public ...